{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:47:13Z","timestamp":1794466033183,"version":"4.9.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Anabolic-androgenic steroids (AASs) are often used by men for bodybuilding and to improve sports performance. The use is not limited to professional competitive athletes, but many amateur men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of this study was to assess and systematically review the effects of AAS on male fertility parameters, spermiogram, testosterone, follicle-stimulating hormone (FSH) and luteinising hormone (LH) and to review reversibility and other morbidity impacting fertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Eligibility criteria - We included studies mentioning data about adult males using supraphysiologic doses of AAS for sports performance or appearance enhancement, with comparison data from general population or matched controls if available reporting fertility parameters and sexual performance. Information sources - A systematic literature search was performed using PubMed, MEDLINE, EMBASE, Google Scholar and World of Science. Controlled clinical trials randomised or nonrandomised (if available), case series with or without matched controls, case reports, cross-sectional surveys, reports on follow-up of subjects caught in doping test and their fertility parameters when reported. Risk of bias\/quality assessment - The quality assessment of the included studies was performed using the Newcastle\u2013Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Included studies - Thirty-two studies were included. There were 12 cohort studies, 5 case\u2013control studies, 9 cross-sectional surveys and 6 case reports. The study population comprised 9371 individuals, of which 2671 were AAS users. Synthesis of results - AAS users had reduced levels of FSH and LH than the na\u00efve population. These levels remained low for 3\u20136 months after stopping AAS. One year after stopping AAS, the users and na\u00efve population had insignificant differences in FSH and LH values. The total testosterone (TT) levels were comparable in users and na\u00efve populations at baseline, 3 months and 6 months after stopping, but at 1 year, TT values were lower in AAS users. Sperm concentration in AAS users and na\u00efve population was similar, but sperm motility was lower in AAS users. The testicular size was lower in AAS users. The erectile function improved with AAS use, but on withdrawal, there was decreased libido and erectile dysfunction. Most AAS users need additional medications to mitigate detrimental effects on fertility. Description of the effect - AAS use negatively impacted the gonadotrophin levels and had lower sperm motility and testicular size. Strength - Comprehensive review of 32 publications, study population of 9371 individuals, of which 2671 were AAS users, meta-analysis of reproductive hormones, semen parameters and testis size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>The limitations are small sample size of most of the studies, polypharmacy, lack of information on dosing and high heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation:<\/jats:title>\n                    <jats:p>AAS use is detrimental for sperm motility and has a partially reversible negative impact on male fertility. Users must be cautioned about its negative impact on libido and erectile function.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Registration:<\/jats:bold>\n                      PROSPERO Registration No. CRD42023411294.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_90_23","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T19:00:07Z","timestamp":1703876407000},"page":"268-285","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis"],"prefix":"10.4103","volume":"16","author":[{"given":"Prashant Motiram","family":"Mulawkar","sequence":"first","affiliation":[{"name":"Urology, Tirthankar Superspeciality Hospital, Mumbai, India"},{"name":"Department of Urology, GMC and SSH, Mumbai, India"},{"name":"Urology, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj N.","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Fortis Hospital Mulund, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Gauhar","sequence":"additional","affiliation":[{"name":"Urology, Ng Teng Fong General Hospital, NUHS, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet Gopal","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Urology, Lotus Superspeciality Hospital, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofiq Olayinka","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Urology, University of Ilorin Teaching Hospital, Ilorin, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Gajendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Urology, MPUH, Nadiad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Ramdas","family":"Tak","sequence":"additional","affiliation":[{"name":"Urology, Asian Institute of Nephrology and Urology, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utsav Shailesh","family":"Shah","sequence":"additional","affiliation":[{"name":"Urology, Bodyline Hospitals, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali Parthsarthi","family":"Shukla","sequence":"additional","affiliation":[{"name":"Shukla Test Tube Baby Centre, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Mamankar","sequence":"additional","affiliation":[{"name":"Amardeep IVF and Fertility Centre, Akola, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"R1-20240905","doi-asserted-by":"crossref","first-page":"371!","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"key":"R2-20240905","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/17440572.2013.790312","article-title":"The BALCO scandal: The social structure of a steroid distribution network","volume":"14","author":"Athey","year":"2013","journal-title":"Glob Crime"},{"key":"R4-20240905","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.pmr.2014.06.013","article-title":"Performance-enhancing drugs: Understanding the risks","volume":"25","author":"Hatton","year":"2014","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"R5-20240905","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1600-0447.1990.tb05496.x","article-title":"Illicit anabolic steroid use: A controlled personality study","volume":"81","author":"Yates","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"R6-20240905","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/joim.12885","article-title":"The Mossman-Pacey paradox","volume":"286","author":"Horwitz","year":"2019","journal-title":"J Intern Med"},{"key":"R7-20240905","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/joim.12884","article-title":"The fertility fitness paradox of anabolic-androgenic steroid abuse in men","volume":"286","author":"Mossman","year":"2019","journal-title":"J Intern Med"},{"key":"R8-20240905","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s40279-017-0709-z","article-title":"Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis","volume":"47","author":"Christou","year":"2017","journal-title":"Sports Med"},{"key":"R9-20240905","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5534\/wjmh.210021","article-title":"Consequences of anabolic-androgenic steroid abuse in males;sexual and reproductive perspective","volume":"40","author":"Corona","year":"2022","journal-title":"World J Mens Health"},{"key":"R10-20240905","doi-asserted-by":"crossref","first-page":"e14062","DOI":"10.1111\/and.14062","article-title":"Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review","volume":"53","author":"Vilar Neto","year":"2021","journal-title":"Andrologia"},{"key":"R11-20240905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.23736\/S0031-0808.22.04677-8","article-title":"Impact of anabolic androgenic steroids on male sexual and reproductive function: A systematic review","volume":"65","author":"Esposito","year":"2023","journal-title":"Panminerva Med"},{"key":"R14-20240905","doi-asserted-by":"crossref","first-page":"e14576","DOI":"10.1111\/and.14576","article-title":"The deleterious effects of anabolic androgenic steroid abuse on sexual and reproductive health and comparison of recovery between treated and untreated patients: Single-center prospective randomized study","volume":"54","author":"Al Hashimi","year":"2022","journal-title":"Andrologia"},{"key":"R15-20240905","first-page":"159","article-title":"Effect of anabolic-androgenic steroids on semen parameters and serum hormonal levels in Iraqi male bodybuilders","volume":"45","author":"Al-Janabi","year":"2011","journal-title":"Jordan Med J"},{"key":"R16-20240905","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2007-965808","article-title":"Side effects of anabolic androgenic steroids abuse","volume":"29","author":"Bonetti","year":"2008","journal-title":"Int J Sports Med"},{"key":"R17-20240905","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0034-1398492","article-title":"The response to gonadotropin-releasing hormone and HCG in men with prior chronic androgen steroid abuse and clinical hypogonadism","volume":"47","author":"Flanagan","year":"2015","journal-title":"Horm Metab Res"},{"key":"R18-20240905","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsbmb.2011.08.005","article-title":"Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids","volume":"127","author":"G\u00e5revik","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-20240905","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/joim.12850","article-title":"Health consequences of androgenic anabolic steroid use","volume":"285","author":"Horwitz","year":"2019","journal-title":"J Intern Med"},{"key":"R20-20240905","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/add.12850","article-title":"Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: An under-recognized problem","volume":"110","author":"Kanayama","year":"2015","journal-title":"Addiction"},{"key":"R21-20240905","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-819936","article-title":"Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes","volume":"25","author":"Karila","year":"2004","journal-title":"Int J Sports Med"},{"key":"R22-20240905","first-page":"1643","article-title":"Effect of anabolic-androgenic and nutritional supplements on the reproductive hormone, the hematological parameters and baldness of athletes in Baghdad city","volume":"10","author":"Rahman","year":"2018","journal-title":"J Pharm Sci Res"},{"key":"R23-20240905","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/humrep\/deaa366","article-title":"Disruption and recovery of testicular function during and after androgen abuse: The HAARLEM study","volume":"36","author":"Smit","year":"2021","journal-title":"Hum Reprod"},{"key":"R24-20240905","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-0760(03)00105-5","article-title":"Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers","volume":"84","author":"Urhausen","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R25-20240905","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1210\/clinem\/dgaa837","article-title":"Male fertility before and after androgen abuse","volume":"106","author":"Windfeld-Mathiasen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20240905","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5694\/j.1326-5377.2000.tb125667.x","article-title":"Anabolic-androgenic steroids: Medical assessment of present, past and potential users","volume":"173","author":"O'Sullivan","year":"2000","journal-title":"Med J Aust"},{"key":"R27-20240905","doi-asserted-by":"crossref","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: A case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"key":"R28-20240905","doi-asserted-by":"crossref","first-page":"dgz324","DOI":"10.1210\/clinem\/dgz324","article-title":"Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men","volume":"105","author":"Shankara-Narayana","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20240905","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.15218\/zjms.2017.021","article-title":"Nandrolone effects on men's semen parameters in Erbil city","volume":"21","author":"Sharef","year":"2017","journal-title":"Zanco J Med Sci"},{"key":"R30-20240905","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0024-3205(01)00972-9","article-title":"Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders","volume":"68","author":"Torres-Calleja","year":"2001","journal-title":"Life Sci"},{"key":"R31-20240905","doi-asserted-by":"crossref","first-page":"483","DOI":"10.21037\/tau.2018.04.23","article-title":"Impact of anabolic androgenic steroids on sexual function","volume":"7","author":"Armstrong","year":"2018","journal-title":"Transl Androl Urol"},{"key":"R32-20240905","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.21037\/tau.2018.05.05","article-title":"Medication patterns and fertility rates in a cohort of anabolic steroid users","volume":"7","author":"Avant","year":"2018","journal-title":"Transl Androl Urol"},{"key":"R33-20240905","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.juro.2013.06.010","article-title":"Anabolic steroid induced hypogonadism in young men","volume":"190","author":"Coward","year":"2013","journal-title":"J Urol"},{"key":"R34-20240905","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/09687637.2021.1882940","article-title":"Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: A mixed-methods study","volume":"29","author":"Harvey","year":"2022","journal-title":"Drugs Educ Prev Policy"},{"key":"R35-20240905","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.sapharm.2018.07.003","article-title":"Anabolic steroid users'misuse of non-traditional prescription drugs","volume":"15","author":"Ip","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"R36-20240905","first-page":"872","article-title":"Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility","volume":"47","author":"Kovac","year":"2015","journal-title":"Andrologia"},{"key":"R37-20240905","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.jsm.0000180872.22426.bb","article-title":"Anabolic steroid use in weightlifters and bodybuilders: An internet survey of drug utilization","volume":"15","author":"Perry","year":"2005","journal-title":"Clin J Sport Med"},{"key":"R38-20240905","first-page":"163","article-title":"Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran","volume":"14","author":"Razavi","year":"2014","journal-title":"J Res Health Sci"},{"key":"R39-20240905","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0091450917694268","article-title":"Adverse effects, health service engagement, and service satisfaction among anabolic androgenic steroid users","volume":"44","author":"Zahnow","year":"2017","journal-title":"Contemp Drug Probl"},{"key":"R40-20240905","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12024-018-0015-6","article-title":"Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids","volume":"14","author":"Alibegovi\u0107","year":"2018","journal-title":"Forensic Sci Med Pathol"},{"key":"R41-20240905","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.fertnstert.2011.04.029","article-title":"Persistent primary hypogonadism associated with anabolic steroid abuse","volume":"96","author":"Boregowda","year":"2011","journal-title":"Fertil Steril"},{"key":"R42-20240905","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.jsxm.2016.03.238","article-title":"P-03-017 Hypogonadism persistence after long-term illicit use of anabolic-androgenic steroids","volume":"13","author":"Coxon","year":"2016","journal-title":"J Sex Med"},{"issue":"Suppl 3","key":"R43-20240905","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0015-0282(03)00365-0","article-title":"Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin","volume":"79","author":"Menon","year":"2003","journal-title":"Fertil Steril"},{"key":"R44-20240905","doi-asserted-by":"crossref","first-page":"3.e1","DOI":"10.1016\/j.fertnstert.2010.03.042","article-title":"Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism","volume":"94","author":"Pirola","year":"2010","journal-title":"Fertil Steril"},{"key":"R45-20240905","doi-asserted-by":"crossref","first-page":"e13107","DOI":"10.1111\/and.13107","article-title":"Disorder of hypothalamic-pituitary-gonadal axis induced by abusing of anabolic-androgenic steroids for short time: A case report","volume":"50","author":"Vilar Neto","year":"2018","journal-title":"Andrologia"},{"key":"R46-20240905","first-page":"43","article-title":"Anabolic steroid: Effects on strength, body weight, oxygen uptake and spermatogenesis upon mature males","volume":"4","author":"Johnson","year":"1972","journal-title":"Med Sci Sports"},{"key":"R47-20240905","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365517709100649","article-title":"Effect of short-term treatment with an anabolic steroid (methandienone) and dehydroepiandrosterone sulphate on plasma hormones, red cell volume and 2,3-diphosphoglycerate in athletes","volume":"37","author":"Remes","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"R48-20240905","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1530\/acta.0.0830856","article-title":"Effect of an anabolic steroid (metandienon) on plasma LH, FSH, and testosterone and on the response to intravenous administration of LRH","volume":"83","author":"Holma","year":"1976","journal-title":"Eur J Endocrinol"},{"key":"R49-20240905","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(84)91752-5","article-title":"Reversible azoospermia induced by the anabolic steroid 19-nortestosterone","volume":"1","author":"Sch\u00fcrmeyer","year":"1984","journal-title":"Lancet"},{"key":"R50-20240905","first-page":"354","article-title":"Response of serum hormones to androgen administration in power athletes","volume":"17","author":"Al\u00e9n","year":"1985","journal-title":"Med Sci Sports Exerc"},{"key":"R51-20240905","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/036354658701500411","article-title":"Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes","volume":"15","author":"Al\u00e8n","year":"1987","journal-title":"Am J Sports Med"},{"key":"R52-20240905","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1530\/acta.0.0770380","article-title":"The effect of mesterolone administration to normal men on the pituitary-testicular function","volume":"77","author":"Aakvaag","year":"1974","journal-title":"Eur J Endocrinol"},{"key":"R53-20240905","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0140-6736(76)90001-5","article-title":"\u201cAnabolic\u201d effects of methandienone in men undergoing athletic training","volume":"2","author":"Hervey","year":"1976","journal-title":"Lancet"},{"key":"R54-20240905","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-4731(85)90257-2","article-title":"Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man","volume":"23","author":"Ruokonen","year":"1985","journal-title":"J Steroid Biochem"},{"key":"R55-20240905","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: An integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"R56-20240905","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00913847.2018.1526626","article-title":"Anabolic-androgenic steroids: Procurement and administration practices of doping athletes","volume":"47","author":"Fink","year":"2019","journal-title":"Phys Sportsmed"},{"key":"R57-20240905","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2018-01882","article-title":"Diagnosis and management of anabolic androgenic steroid use","volume":"104","author":"Anawalt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"key":"R59-20240905","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2004.00298.x","article-title":"Pharmacoepidemiology of anabolic androgenic steroids: A review","volume":"19","author":"Thiblin","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"R60-20240905","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","article-title":"Anabolic androgenic steroids: A survey of 500 users","volume":"38","author":"Parkinson","year":"2006","journal-title":"Med Sci Sports Exerc"},{"key":"R61-20240905","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"key":"R62-20240905","doi-asserted-by":"crossref","first-page":"1059473","DOI":"10.3389\/fendo.2022.1059473","article-title":"Anabolic\u2013androgenic steroids: How do they work and what are the risks?","volume":"13","author":"Bond","year":"2022","journal-title":"Front Endocrinol"},{"key":"R63-20240905","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.disamonth.2013.03.010","article-title":"Anabolic-androgenic steroids","volume":"59","author":"Barceloux","year":"2013","journal-title":"Dis Mon"},{"key":"R64-20240905","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7497346","article-title":"Anabolic-androgenic steroid misuse: mechanisms, patterns of misuse, user typology, and adverse Effects","volume":"2021","author":"Ding","year":"2021","journal-title":"J Sports Med"},{"key":"R65-20240905","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-5273(02)00247-4","article-title":"Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting","volume":"85","author":"Mulligan","year":"2002","journal-title":"Int J Cardiol"},{"key":"R66-20240905","doi-asserted-by":"crossref","first-page":"643954","DOI":"10.1155\/2013\/643954","article-title":"Muscle wasting in hemodialysis patients: New therapeutic strategies for resolving an old problem","volume":"2013","author":"Chen","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"R67-20240905","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1479972308092350","article-title":"Anabolic steroids in COPD: A review and preliminary results of a randomized trial","volume":"5","author":"Sharma","year":"2008","journal-title":"Chron Respir Dis"},{"key":"R68-20240905","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11934-016-0629-8","article-title":"Novel uses for the anabolic androgenic steroids nandrolone and oxandrolone in the management of male health","volume":"17","author":"Wu","year":"2016","journal-title":"Curr Urol Rep"},{"key":"R69-20240905","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: Diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil Steril"},{"key":"R70-20240905","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/09687637.2018.1488947","article-title":"An evidence-based socioecological framework to understand men's use of anabolic androgenic steroids and inform interventions in this area","volume":"26","author":"Bates","year":"2019","journal-title":"Drugs Educ Prev Policy"},{"key":"R71-20240905","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17446651.2021.1921574","article-title":"Anabolic steroid misuse and male infertility: Management and strategies to improve patient awareness","volume":"16","author":"Whitaker","year":"2021","journal-title":"Expert Rev Endocrinol Metab"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_90_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:57:53Z","timestamp":1787763473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_90_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_90_23","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}